Cotton fabrics were dyed with the madder and compounds of citric acid (CA) and dicarboxylic acids [tartaric acid (TTA), malic acid (MLA), succinic acid (SUA)] as cross-linking agents and sodium hypophosphite (SHP) as the catalyst. The molecular structures and crystal structures of the dyed cotton fabrics were analyzed using Fourier-transform infrared spectroscopy (FTIR) and X-ray diffractometry (XRD), respectively. The results showed that the polycarboxylic acids esterified with the hydroxyl groups in the dye and cellulose, respectively, and the reaction mainly occurred in the amorphous region of the cotton fabric. Compared with the direct dyed cotton fabric, the surface color depth (K/S) values of the CA, CA+TTA, CA+MLA, CA+SUA cross-linked dyed cotton fabrics increased by approximately 160%, 190%, 240%, 270%, respectively. The CA+SUA cross-linked dyed cotton fabric achieved the biggest K/S value due to the elimination of the negative effect by α-hydroxyl in TTA and MLA on esterification reaction, and the cross-linked dyed cotton fabrics had great levelness property. The washing and rubbing fastness of the cross-linked cotton fabrics were above four levels. The light resistance stability and the antibacterial property of the cross-linked dyed cotton fabrics was obviously improved. The sum of warp and weft wrinkle recovery angle (WRA) of the CA+SUA cross-linked dyed cotton fabric was 55° higher than that of raw cotton fabric, and its average UV transmittance for UVA was less than 5% and its UPF value was 50+, showing a great anti-wrinkle and anti-ultraviolet properties.
The effectiveness and safety of mesenchymal stem cell (MSC) therapy have been substantiated across various diseases. Nevertheless, challenges such as the restricted in vitro expansion capacity of tissue‐derived MSCs and the clinical instability due to the high heterogeneity of isolated cells require urgent resolution. The induced pluripotent stem cell‐derived MSCs (iPSC‐MSCs), which is differentiated from iPSCs via specific experimental pathways, holds considerable potential as a substitute for tissue derived MSCs. Multiple studies have demonstrated that iPSCs can be differentiated into iPSC‐MSCs through diverse differentiation strategies. Research suggests that iPSC‐MSCs, when compared to tissue derived MSCs, exhibit superior characteristics in terms of proliferation ability, immune modulation capacity, and biological efficiency. In this review, we meticulously described and summarized the experimental methods of iPSC differentiation into iPSC‐MSCs, the application of iPSC‐MSCs in various disease models, the latest advancements in clinically relevant iPSC‐derived cell products, and the development strategies for the next generation of iPSC‐derived therapy products (not only cell products but also their derivatives).